Wildcat Capital Management as of June 30, 2016
Portfolio Holdings for Wildcat Capital Management
Wildcat Capital Management holds 21 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kite Pharma | 33.5 | $118M | 2.4M | 50.00 | |
| Ryanair Holdings (RYAAY) | 24.6 | $86M | 5.7M | 15.28 | |
| CoStar (CSGP) | 15.7 | $55M | 252k | 218.66 | |
| Nantkwest | 8.0 | $28M | 4.5M | 6.22 | |
| Sorrento Therapeutics (SRNE) | 4.5 | $16M | 2.8M | 5.60 | |
| Hilton Worlwide Hldgs | 3.2 | $11M | 505k | 22.53 | |
| MiMedx (MDXG) | 2.5 | $8.6M | 1.1M | 7.98 | |
| S&p 500 Index call | 2.0 | $6.9M | 61k | 112.65 | |
| Lpl Financial Holdings (LPLA) | 1.3 | $4.6M | 207k | 22.32 | |
| Communications Sales&leas Incom us equities / etf's | 1.2 | $4.4M | 151k | 28.90 | |
| Nanthealth | 0.9 | $3.0M | 241k | 12.50 | |
| Ishares Tr option | 0.7 | $2.3M | 27k | 83.89 | |
| Ishares Tr Index option | 0.4 | $1.6M | 14k | 114.29 | |
| Editas Medicine (EDIT) | 0.4 | $1.5M | 60k | 24.41 | |
| Ishares Nasdaq Biotech Indx call | 0.3 | $1.2M | 4.8k | 257.35 | |
| Spdr S&p 500 Etf Tr option | 0.2 | $864k | 4.1k | 209.40 | |
| WisdomTree Japan Total Dividend (DXJ) | 0.2 | $776k | 20k | 38.80 | |
| iShares Barclays 20+ Yr Treas.Bond (TLT) | 0.2 | $669k | 4.8k | 138.45 | |
| Intellia Therapeutics (NTLA) | 0.1 | $534k | 25k | 21.36 | |
| S&p 500 option | 0.1 | $445k | 4.0k | 112.46 | |
| Adverum Biotechnologies | 0.0 | $47k | 15k | 3.13 |
